EUVIMED · CrossrefZeitschrift
ALTEX
ISSN 1868-596X · ALTEX Edition
Neueste Artikel
Pharmaceutical industry perspective on the utility of animal cell-based microphysiological systems to support human drug development
Animal pilot studies should not be used to estimate sample size if effect size and population variance are unknown
Challenges and opportunities for validation of AI-based new approach methods
Making safety decisions for a sunscreen active ingredient using next-generation risk assessment: Benzophenone-4 case study
A path forward advancing microphysiological systems
Ways to broaden the awareness, consideration and adoption of new approach methodologies (NAMs)
An Alternative Safety Profiling Algorithm (ASPA) to transform next generation risk assessment into a structured and transparent process
Qualitative and quantitative concentration-response modelling of gene co-expression networks to unlock hepatotoxic mechanisms for next generation chemical safety assessment
The road to virtual control groups and the importance of proper body-weight selection
The validation of regulatory test methods – Conceptual, ethical, and philosophical foundations
Leveraging biomarkers and translational medicine for preclinical safety - Lessons for advancing the validation of alternatives to animal testing
Organoid intelligence (OI) – The ultimate functionality of a brain microphysiological system
ToxAIcology - The evolving role of artificial intelligence in advancing toxicology and modernizing regulatory science
Toward implementing virtual control groups in nonclinical safety studies
Application of high-throughput transcriptomics for mechanism-based biological read-across of short-chain carboxylic acid analogues of valproic acid
Assessment of a 3D neural spheroid model to detect pharmaceutical-induced neurotoxicity
Probabilistic risk assessment – the keystone for the future of toxicology
Next-generation risk assessment of chemicals – Rolling out a human-centric testing strategy to drive 3R implementation: The RISK-HUNT3R project perspective
Ready for regulatory use: NAMs and NGRA for chemical safety assurance
Comparison of structural equation modeling and Bayesian network for de novo construction of a quantitative adverse outcome pathway network
Microphysiological endothelial models to characterize subcutaneous drug absorption
Microphysiological endothelial models to characterize subcutaneous drug absorption_suppl
Systematic review in evidence-based risk assessment
Educational use of animals in Europe indicates a reluctance to implement alternatives
Using the monocyte activation test as a stand-alone release test for medical devices
Pyrogen testing revisited on occasion of the 25th anniversary of the whole blood monocyte activation test
Retrospective analysis of dermal absorption triple pack data
Applying evidence-based methods to the development and use of adverse outcome pathways
Animal welfare and ethics in the collection of fetal blood for the production of fetal bovine serum
U.S. Federal Agency interests and key considerations for new approach methodologies for nanomaterials
EUVIMED